PRESS RELEASE published on 01/24/2024 at 02:03, 1 year 10 months ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIVI The Rosen Law Firm, a trusted and leading law firm, is announcing a class action lawsuit on behalf of BioVie Inc. investors. The lawsuit alleges that BioVie made misleading statements about its business operations and COVID-19's impact on its clinical trial sites, resulting in damages to investors. If you purchased BioVie securities during the specified period, you may be entitled to compensation. Investors are encouraged to seek qualified counsel and can join the class action by contacting The Rosen Law Firm before the important deadline on March 19, 2024. Rosen Law Firm Securities Class Action Investor Rights Financial Litigation BioVie Inc.
PRESS RELEASE published on 01/24/2024 at 02:03, 1 year 10 months ago ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of AlloVir, Inc. If you purchased AlloVir securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Join the AlloVir class action by visiting the link provided or contacting the stated email and phone numbers for information. The lawsuit alleges that AlloVir made materially false and misleading statements regarding its business, operations, and prospects, leading to damages for investors. Securities Investors Rosen Law Firm Class Action Lawsuit AlloVir
PRESS RELEASE published on 01/24/2024 at 02:02, 1 year 10 months ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX The Rosen Law Firm, a global investor rights law firm, is encouraging Eagle Pharmaceuticals, Inc. investors to seek counsel before the important deadline in the securities class action. Investors who purchased Eagle Pharmaceuticals securities during the specified period may be entitled to compensation without payment of out-of-pocket fees through a contingency fee arrangement. The firm has a track record of success in leadership roles and represents investors in securities class actions and shareholder derivative litigation. For more information on the class action or to join, visit the provided website or contact the firm directly. The lawsuit claims that investors suffered damages, and no class has been certified yet. Rosen Law Firm Securities Class Action Investor Rights Eagle Pharmaceuticals Shareholder Derivative Litigation
PRESS RELEASE published on 01/24/2024 at 01:07, 1 year 10 months ago ROSEN, SKILLED INVESTOR COUNSEL, Encourages Driven Brands Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DRVN The Rosen Law Firm, a global investor rights law firm, is encouraging Driven Brands Holdings Inc. investors with losses to secure counsel before the important February 20, 2024 lead plaintiff deadline. The firm represents investors throughout the globe, with a focus on securities class actions and shareholder derivative litigation, and has a strong track record of success in securing settlements for investors in similar cases. Investors who purchased Driven Brands common stock during the specified period may be entitled to compensation without payment of any out-of-pocket fees through a contingency fee arrangement. For more information on the class action and how to join, visit the Rosen Law Firm's website or contact the firm directly. They emphasize the importance of selecting qualified counsel with a proven record of success in these types of litigation. The lawsuit alleges that the defendants made materially false and misleading statements and omissions regarding the integration of acquired businesses and the performance of the car wash business segment, causing damages to investors. The Rosen Law Firm emphasizes that no class has been certified at this time, and investors may select their own counsel or remain as absent class members. Follow the Rosen Law Firm on social media for updates and news related to the case. Investors Rosen Law Firm Securities Class Action Driven Brands Holdings Inc. Shareholder Derivative Litigation
PRESS RELEASE published on 01/24/2024 at 01:07, 1 year 10 months ago ROSEN, A RANKED AND LEADING FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and October 13, 2023. Investors are encouraged to secure counsel before the important deadline in this securities class action. The Rosen Law Firm represents investors globally in securities class actions and shareholder derivative litigation, with a track record of successful settlements. If you wish to join the BioNTech class action, visit the website or contact for more information. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights Financial Lawsuit
PRESS RELEASE published on 01/24/2024 at 00:06, 1 year 10 months ago ROSEN, A RANKED AND LEADING FIRM, Encourages Cummins Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CMI The Rosen Law Firm, a global investor rights law firm, encourages Cummins Inc. investors to secure counsel before the important deadline in a securities class action first filed by the firm. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation, and has recovered hundreds of millions of dollars for investors. For more information on the class action and to join, visit the Rosen Law Firm's website or contact their representatives. Rosen Law Firm Securities Class Action Investor Rights Cummins Inc. Shareholder Derivative Litigation
PRESS RELEASE published on 01/24/2024 at 00:06, 1 year 10 months ago ROSEN, A RANKED AND LEADING FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important February 5 Deadline in Securities Class Action Filed by the Firm - BRBS The Rosen Law Firm, a leading global investor rights law firm, encourages Blue Ridge Bankshares, Inc. investors to secure counsel before the important February 5 deadline in the securities class action. Investors who purchased Blue Ridge securities during the Class Period may be entitled to compensation without payment of any out-of-pocket fees. The lawsuit alleges that Blue Ridge Bankshares made materially false and/or misleading statements about its financial statements, and investors are urged to select qualified counsel. For more information on the class action, individuals can visit the Rosen Law Firm's website or contact them directly. Rosen Law Firm has a track record of success in securities class actions and has recovered hundreds of millions of dollars for investors. Financial Statements Rosen Law Firm Securities Class Action Investor Rights Blue Ridge Bankshares
PRESS RELEASE published on 01/23/2024 at 23:06, 1 year 10 months ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Dada Nexus Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - DADA Rosen Law Firm, a globally recognized investor rights law firm, reminds investors of the important deadline in the securities class action lawsuit against Dada Nexus Limited. Investors who purchased Dada securities during the specified period may be entitled to compensation and are encouraged to seek qualified counsel. The lawsuit alleges that Dada made materially false and misleading statements, leading to damages for investors. For more information and to join the class action, visit the Rosen Law Firm website. Rosen Law Firm Securities Class Action Investor Rights Compensation Dada Nexus Limited
PRESS RELEASE published on 01/23/2024 at 22:36, 1 year 10 months ago ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fisker Inc. Investors with Losses to Secure Counsel Before Important January 26 Deadline in Securities Class Action - FSR The Rosen Law Firm, a global investor rights law firm, is encouraging Fisker Inc. investors with losses to secure counsel before the important January 26, 2024 deadline in the securities class action. Investors may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. To join the class action, individuals can visit the Rosen Law Firm website or contact their legal team. The lawsuit claims that investors suffered damages due to materially false and/or misleading statements by the defendants. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Investors Rosen Law Firm Securities Class Action Compensation Fisker Inc.
PRESS RELEASE published on 01/23/2024 at 20:03, 1 year 10 months ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF The Rosen Law Firm, a globally recognized investor rights law firm, is investigating potential securities claims on behalf of Grifols, S.A. investors due to allegations of misleading business information. Investors may be entitled to compensation and are encouraged to join the prospective class action. The firm has a strong track record in securities class actions and shareholder derivative litigation, and has recovered hundreds of millions of dollars for investors. Contact the firm for more information. Rosen Law Firm Securities Class Action Investor Rights Grifols SA Stock Market Manipulation
Published on 12/05/2025 at 21:20, 12 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 32 minutes ago The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 7 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 1 hour 17 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 42 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 18:58, 2 hours 34 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 3 hours 17 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 3 hours 46 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 4 hours 14 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 14 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 22 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 22 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 34 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE